^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Peripheral T-cell Lymphoma |
| Regimen: | EPOCH (cyclophosphamide + doxorubicin hydrochloride + etoposide IV + methylprednisolone oral + vincristine) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
12/22/2021
Excerpt:
Peripheral T- cell Lymphomas...Other recommended regimens...Dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin)
